Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Mandelboim

Showing results (71-80 of 231) with videos related to

Pageof 24
Sort By:
Cell Reports|July 7, 2017
Stromal Cell-Derived Factor 1 Mediates Immune Cell Attraction upon Urinary Tract InfectionBatya Isaacson, Tehila Hadad, Ariella Glasner, et al.
Blood|August 12, 2009
Dynamic behavior of NK cells during activation in lymph nodesHélène Beuneu, Jacques Deguine, Béatrice Breart, et al.
Cell Reports|June 3, 2014
NK cell receptor NKp46 regulates graft-versus-host diseaseHormas Ghadially, Meir Ohana, Moran Elboim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2012
Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1Ariella Glasner, Hormas Ghadially, Chamutal Gur, et al.
Cellular & Molecular Immunology|October 3, 2018
Targeting PVR (CD155) and its receptors in anti-tumor therapyPaola Kučan Brlić, Tihana Lenac Roviš, Guy Cinamon, et al.
European Journal of Immunology|July 16, 2021
The inhibitory receptor CD300a is essential for neutrophil-mediated clearance of urinary tract infection in miceBatya Isaacson, Maya Baron, Rachel Yamin, et al.
Nature Communications|April 7, 2021
A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domainEinat Seidel, Liat Dassa, Shira Kahlon, et al.
Oncotarget|March 31, 2016
PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functionsYael Ophir, Alexandra Duev-Cohen, Rachel Yamin, et al.
Oncotarget|June 17, 2015
Characterization of tumor infiltrating natural killer cell subsetInbar Levi, Hagai Amsalem, Aviram Nissan, et al.
Oncoimmunology|May 10, 2019
<i>Fusobacterium nucleatum</i> supresses anti-tumor immunity by activating CEACAM1Chamutal Gur, Naseem Maalouf, Amjad Shhadeh, et al.
Pageof 24

Showing results (71-80 of 231) with videos related to

Sort By:
Pageof 24
Cell Reports|July 7, 2017
Stromal Cell-Derived Factor 1 Mediates Immune Cell Attraction upon Urinary Tract InfectionBatya Isaacson, Tehila Hadad, Ariella Glasner, et al.
Blood|August 12, 2009
Dynamic behavior of NK cells during activation in lymph nodesHélène Beuneu, Jacques Deguine, Béatrice Breart, et al.
Cell Reports|June 3, 2014
NK cell receptor NKp46 regulates graft-versus-host diseaseHormas Ghadially, Meir Ohana, Moran Elboim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2012
Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1Ariella Glasner, Hormas Ghadially, Chamutal Gur, et al.
Cellular & Molecular Immunology|October 3, 2018
Targeting PVR (CD155) and its receptors in anti-tumor therapyPaola Kučan Brlić, Tihana Lenac Roviš, Guy Cinamon, et al.
European Journal of Immunology|July 16, 2021
The inhibitory receptor CD300a is essential for neutrophil-mediated clearance of urinary tract infection in miceBatya Isaacson, Maya Baron, Rachel Yamin, et al.
Nature Communications|April 7, 2021
A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domainEinat Seidel, Liat Dassa, Shira Kahlon, et al.
Oncotarget|March 31, 2016
PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functionsYael Ophir, Alexandra Duev-Cohen, Rachel Yamin, et al.
Oncotarget|June 17, 2015
Characterization of tumor infiltrating natural killer cell subsetInbar Levi, Hagai Amsalem, Aviram Nissan, et al.
Oncoimmunology|May 10, 2019
<i>Fusobacterium nucleatum</i> supresses anti-tumor immunity by activating CEACAM1Chamutal Gur, Naseem Maalouf, Amjad Shhadeh, et al.
Pageof 24